VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim Labs”), a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in ...

Linda Burghardt, PhD, a researcher in Great Neck, New York, started taking semaglutide because her doctor thought it might ...

MentorCloud wrapped up 2025 with global growth, reinforcing a human-first approach to AI as it heads into deeper Human+AI mentoring in 2026. The way AI has challenged every leader to adopt widely, we ...

Analytical Biological Services, Inc. ("ABS Bio" or "the Company"), a 3 Boomerang Capital ("3 Boomerang" or "3BC") portfolio ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

The company’s AI-builder approach with in-house AI innovation and bolt-on acquisitions will be key for its growth in the ...

The 2026 ACS president will spend the society's 150th anniversary focusing on growing ACS's platform and engaging its members ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

As geopolitical tensions rise, competition for the cutting-edge science and talent that underpins advanced technology has ...

Miami-based investment firm HIG Capital has divested United Flow Technologies to Berkshire Partners while maintaining a ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...